Traumatic brain injury outcomes improve with progesteroneProviding progesterone to victims with Traumatic Brain Injury (TBI) shortly after the injury could minimize the risk of death and the degree of disability besides being safe, according to a study by researchers from Emory University.

The study disclosed that progesterone treatment for TBI has been extensively studied in laboratory animals for more than fifteen years and has demonstrated efficacy by reducing brain swelling, improved functional outcomes, and prevention of nerve death.

The research was published in the Annals of Emergency Medicine.